The year in cancer: Advances made in 2024, predictions for 2025

by specific biomarkers, which means treatments can be more precisely tailored to the genetic makeup of a person’s cancer,\” said Subbiah. (iStock)Q: What are your predictions for cancer research in 2025?A: In 2025, I predict we will see more approvals for precision oncology drugs that target specific genetic mutations, as well as more approvals for immunotherapies and combination therapies. I also anticipate an increase in the use of liquid biopsies to monitor treatment response and identify resistance mechanisms to therapies. Q: How has the state of cancer in your specialty area changed and evolved over the past decade?A: Over the past decade, we have seen a shift towards precision medicine and targeted therapies in oncology. We are now able to identify specific genetic mutations in a patient’s tumor and tailor treatment based on those mutations, leading to more effective and less toxic therapies. This personalized approach has revolutionized cancer care and has significantly improved outcomes for many patients. Q: What can people do to reduce their cancer risk?A: To reduce cancer risk, it is important to maintain a healthy lifestyle, including eating a balanced diet, exercising regularly, avoiding tobacco and excessive alcohol consumption, and protecting oneself from excessive sun exposure. Regular screenings and check-ups are also important for early detection of cancer. Q: Anything else people should know?A: Cancer research is rapidly advancing, and there is hope on the horizon for more effective and targeted treatments for cancer. Clinical trials play a crucial role in advancing cancer care and providing patients with access to cutting-edge therapies. Patients should consider participating in clinical trials as a way to contribute to the future of cancer treatment and potentially benefit from new and innovative therapies.